MMP-1,-3,-7,-9,-10 and -12 were significantly upregulated in patients with pancreatic cancer (p < 0.0001, respectively), whereas MMP-2 was significantly decreased in the cancer patient group (p < 0.0001; Figure 2A). The gene discussed is MMP1; the disease is familial pancreatic carcinoma.